Addressing the Ongoing Plasma / Ig Shortage
Since late 2018, the Immune Deficiency Foundation (IDF) has been tracking a troubling shortage of plasma-based immunoglobulin (Ig) products, which are lifesaving, lifelong treatments for people with primary immunodeficiencies (PI), specifically those who are antibody deficient. We continue to monitor the situation day-to-day and week-to-week and offer guidance and input where we can to make a difference.